Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.
about
Tipping the balance between good and evil: aberrant 14-3-3ζ expression drives oncogenic TGF-β signaling in metastatic breast cancersc-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expressionCystatin A suppresses tumor cell growth through inhibiting epithelial to mesenchymal transition in human lung cancer.
P2860
Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.
@ast
Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.
@en
type
label
Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.
@ast
Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.
@en
prefLabel
Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.
@ast
Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.
@en
P2860
P356
P1476
Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.
@en
P2093
William P Schiemann
Yong-Hun Lee
P2860
P356
10.2217/BMT.13.74
P577
2014-01-01T00:00:00Z